Zobrazeno 1 - 10
of 135
pro vyhledávání: '"Viral Relapse"'
Autor:
Ken Kurokawa, Takamasa Ohki, Jun Kato, Yukiyo Fukumura, Makoto Imai, Chikako Shibata, Junya Arai, Mayuko Kondo, Kaoru Takagi, Kentaro Kojima, Michiharu Seki, Masaya Mori, Nobuo Toda, Kazumi Tagawa
Publikováno v:
Journal of Medical Case Reports, Vol 14, Iss 1, Pp 1-6 (2020)
Abstract Background Combination therapy of interferon and ribavirin has traditionally been used to eradicate hepatitis C virus. The sustained virologic response achieved with interferon-related therapy is persistent, and late relapses after achieving
Externí odkaz:
https://doaj.org/article/02fc2fcf54ae4999bef82c837bc6d003
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
P. Lehmann, Svenja Hardtke, Benjamin Maasoumy, Michael P. Manns, Markus Cornberg, Cihan Yurdaydin, Heiner Wedemeyer, Benjamin Heidrich, Birgit Bremer, Katja Deterding, Lisa Sandmann
Publikováno v:
Hepatology Communications
Standard treatment of hepatitis delta virus (HDV) infection remains pegylated-interferon alfa (peg-IFN?) in most centers, which is not only associated with rather low efficacy but several adverse events. Hepatitis B core-related antigen (HBcrAg) is l
Autor:
Venkat Ramanathan, Taaj Raasikh, Avegail G. Flores, Taher Jamali, Ronald T. Cotton, Henkie P. Tan, Ruben Hernaez
Publikováno v:
Alimentary Pharmacology & Therapeutics. 54:571-582
Background Given the success of direct-acting antivirals (DAAs) in treating hepatitis C (HCV), interest is growing in utilizing solid organs from allografts with active HCV to expand donor availability. Aim To review post-transplant outcomes and pati
Publikováno v:
Journal of Clinical Gastroenterology
Supplemental Digital Content is available in the text.
Aims: This study aimed to investigate the dynamic pattern of serum hepatitis B virus (HBV) RNA in chronic hepatitis B (CHB) patients on long-term nucleos(t)ide analogue (NA) therapy and eval
Aims: This study aimed to investigate the dynamic pattern of serum hepatitis B virus (HBV) RNA in chronic hepatitis B (CHB) patients on long-term nucleos(t)ide analogue (NA) therapy and eval
Publikováno v:
Chinese Science Bulletin. 65:1529-1545
Chronic infection of hepatitis B virus (HBV) is still one of the public health concerns affecting human health. Although the prophylactic HBV vaccines was introduced over three decades ago, the total number of chronic hepatitis B (CHB) infection stil
Autor:
Yasuhiro Asahina, Toshikazu Nakano, Hiroshi Yatsuhashi, Yosuke Hagiwara, Tetsuo Takehara, Yuhan Huang, Hiroko Shimizu, Leen Vijgen, Yasuhito Tanaka, Masayuki Kurosaki, Naoki Hiramatsu, Akito Nozaki, Kazuaki Chayama, Norio Hayashi, Hiroki Yoshida, Naoya Sakamoto, Michael Biermer
Publikováno v:
Journal of Gastroenterology
Background The efficacy, safety, and pharmacokinetics of the combination of three direct-acting antiviral (DAA) agents (adafosbuvir [also known as AL-335], odalasvir, and simeprevir) were investigated in DAA treatment-naïve Japanese patients with ge
Autor:
Al Ashgar Hamad, Khan Mohammed, Helmy Ahmed, Al Swat Khalid, Al Shehri Abdullah, Al Kalbani Abdalla, Peedikayel Musthafa, Al Kahtani Khalid, Al Quaiz Mohammed, Rezeig Mohammed, Kagevi Ingvar, Al Fadda Mohammed
Publikováno v:
The Saudi Journal of Gastroenterology, Vol 14, Iss 2, Pp 58-65 (2008)
Background/Aim: This retrospective study assessed the efficacy, safety, and the predictors of sustained viral response (SVR) to a 48-week-course of peginterferon α-2a (Pegasys) and ribavirin combination therapy in 335 consecutive Saudi patients with
Externí odkaz:
https://doaj.org/article/efeb7aaec2754ff585b3edf571dbe218
Autor:
Cesare Ernesto Maria Gruber, Marzia Montalbano, Gianpiero D'Offizi, Martina Rueca, Andrea Antinori, Chiara Taibi, Maria Rosaria Capobianchi, Claudia Minosse, Mauro Zaccarelli, Anna Rosa Garbuglia, Fiona McPhee, Elisabetta Grilli
Publikováno v:
Viruses
Viruses, Vol 13, Iss 1151, p 1151 (2021)
Volume 13
Issue 6
Viruses, Vol 13, Iss 1151, p 1151 (2021)
Volume 13
Issue 6
The risk of hepatitis C virus (HCV) recurrence after direct-acting antiviral (DAA) treatment is <
0.5%. However, the distinction between HCV RNA late relapse and reinfection still represents a challenge in virological diagnostics. The aim of t
0.5%. However, the distinction between HCV RNA late relapse and reinfection still represents a challenge in virological diagnostics. The aim of t
Autor:
Andreea Andronesi, Roxana Jurubiță, Laura Iliescu, Catalin Baston, Nicolae Leca, Bogdan Sorohan, Raluca Bobeica, Bogdan Obrișcă, Gener Ismail
Publikováno v:
Clinical Rheumatology. 38:3677-3687
Newer treatment protocols involving direct-acting antiviral agents (DAAs) have been associated with high rates of sustained virologic response (SVR) and clinical remission in patients with hepatitis C virus (HCV) associated cryoglobulinemic vasculiti